List of works - Kyoichi Kaira

A phase II study of afatinib treatment for elderly patients with previously untreated advanced non-small-cell lung cancer harboring EGFR mutations

scientific article published on 13 October 2018

A phase II study of daily carboplatin plus irradiation followed by durvalumab for stage III non-small cell lung cancer patients with PS 2 up to 74 years old and patients with PS 0 or 1 from 75 years: NEJ039A (trial in progress)

scientific article published on 06 October 2020

A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients

scientific article published on 31 July 2017

An Exploratory Randomized Phase II Trial Comparing CDDP Plus S-1 With Bevacizumab and CDDP Plus Pemetrexed With Bevacizumab Against Patients With Advanced Non-squamous Non-small Cell Lung Cancer

scientific article published on 01 May 2019

Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non-small cell lung cancer: Management of adverse events

scientific article published on 11 March 2020

Clinical Impact of Post-Progression Survival on Overall Survival in Elderly Patients with Non-Small-Cell Lung Cancer Harboring Sensitive EGFR Mutations Treated with First-Line EGFR Tyrosine Kinase Inhibitors

scientific article published on 14 August 2018

Clinical Significance of Various Drug-Sensitivity Markers in Patients with Surgically Resected Pulmonary Pleomorphic Carcinoma

scientific article published on 24 October 2019

Clinical Significance of the Relationship between Progression-Free Survival or Postprogression Survival and Overall Survival in Patients with Extensive Disease-Small-Cell Lung Cancer Treated with Carboplatin plus Etoposide

scientific article published on 29 June 2016

Clinical impact of post-progression survival on overall survival in elderly patients with extensive disease small-cell lung cancer

scientific article published on August 2016

Clinical significance of post-progression survival in lung cancer

scientific article published on 19 June 2017

Clinical significance of primary prophylactic pegylated-granulocyte-colony stimulating factor after the administration of ramucirumab plus docetaxel in patients with previously treated non-small cell lung cancer

scientific article published on 11 March 2019

Clinical significance of topoisomerase-II expression in patients with advanced non-small cell lung cancer treated with amrubicin

scientific article published on 03 January 2020

Different incidence of interstitial lung disease according to different kinds of EGFR-tyrosine kinase inhibitors administered immediately before and/or after anti-PD-1 antibodies in lung cancer

scientific article published on 12 March 2019

Effect of durvalumab on local control after concurrent chemoradiotherapy for locally advanced non-small cell lung cancer in comparison with chemoradiotherapy alone

scientific article published on 01 December 2020

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis

scientific article published on 26 August 2020

Efficacy and safety of cytotoxic drug chemotherapy after first-line EGFR-TKI treatment in elderly patients with non-small-cell lung cancer harboring sensitive EGFR mutations.

scientific article

Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer

scientific article published on 18 December 2019

Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer

scientific article published on 19 March 2020

Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer

scientific article published on 06 February 2017

First-line gefitinib treatment in elderly patients (aged ≥75 years) with non-small cell lung cancer harboring EGFR mutations

scientific article published on 8 August 2015

Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non-small cell lung cancer receiving EGFR-TKI treatment

scientific article published on 03 June 2020

High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinoma

scientific article published on 26 May 2017

Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non-small cell lung cancer patients

scientific article published on 27 February 2019

Intrapericardial carboplatin in the management of malignant pericardial effusion in breast cancer: a pilot study

scientific article published on 27 June 2019

Phase I study of nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer

scientific article published on 19 December 2016

Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel as Second- or Third-Line Therapy in Patients with Advanced Non-Small Cell Lung Cancer

scientific article published on 16 July 2020

Phase II study of oral S-1 plus cisplatin with bevacizumab for advanced non-squamous non-small cell lung cancer

scientific article

Phase II study of weekly docetaxel and cisplatin in patients with non-small cell lung cancer

scientific article published in April 2005

Post-Progression Survival Associated with Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Docetaxel Monotherapy as Second-Line Chemotherapy

scientific article published on 6 April 2017

Post-progression survival is highly linked to overall survival in patients with non-small-cell lung cancer harboring sensitive EGFR mutations treated with first-line epidermal growth factor receptor-tyrosine kinase inhibitors

scientific article published on 08 October 2019

Post-progression survival is strongly linked to overall survival in refractory small-cell lung cancer patients who received amrubicin

scientific article published on 01 July 2020

Potential of FDG-PET as Prognostic Significance after anti-PD-1 Antibody against Patients with Previously Treated Non-Small Cell Lung Cancer

scientific article published on 07 March 2020

Pre-existing interstitial lung disease does not affect prognosis in non-small cell lung cancer patients with PD-L1 expression ≥50% on first-line pembrolizumab

scientific article published on 13 November 2020

Primary thymic adenocarcinoma with an aggressive clinical course: An autopsy case showing signet ring cell-like features

scientific article published on 12 October 2020

Prognostic Significance of Glucose Metabolism as GLUT1 in Patients with Pulmonary Pleomorphic Carcinoma

scientific article published on 03 February 2020

Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors

scientific article published on 19 June 2017

Prognostic value of morphological characteristics assessed by CT scan in patients with non-small cell lung cancer treated with nivolumab

scientific article published on 12 October 2020

Prospective Feasibility Study of Amrubicin and Bevacizumab Therapy for Patients With Previously Treated Advanced NSCLC

scientific article published on 01 March 2020

Radiotherapy is an independent prognostic marker of favorable prognosis in non-small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab

scientific article published on 19 March 2019

Severe hepatotoxicity due to osimertinib after nivolumab therapy in patients with non-small cell lung cancer harboring EGFR mutation

scientific article published on 18 February 2020

Spontaneous aspiration of a long tree twig as foreign body

scientific article published on 01 February 2019

Successful afatinib treatment of advanced non-small-cell lung cancer patients undergoing hemodialysis.

scientific article published on 29 November 2016

The effect of post-progression survival on overall survival among patients with sensitive relapse of small cell lung cancer.

scientific article published on 5 March 2018

Topotecan monotherapy for the treatment of relapsed small cell lung cancer in elderly patients: A retrospective analysis

scientific article published on 3 October 2018

Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer

scientific article published on 14 September 2020

Uptake of positron emission tomography tracers reflects the tumor immune status in esophageal squamous cell carcinoma

scientific article published on 17 April 2020

Verrucous skin lesion caused by neuropathy misdiagnosed as squamous cell carcinoma and treated with amputation surgery

scientific article published on 05 March 2020

List of works by Kyoichi Kaira